| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |